QA1.71 Billable / specific Lynch syndrome

ICD-10-CM QA1.71 identifies “Lynch syndrome” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 17: Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders

Exempt from present-on-admission reporting

Code-level instructions

Inclusion terms6
  • Hereditary nonpolyposis colorectal cancer susceptibility
  • Lynch syndrome due to EPCAM
  • Lynch syndrome due to MLH1
  • Lynch syndrome due to MSH2
  • Lynch syndrome due to MSH6
  • Lynch syndrome due to PMS2

Inherited instructions

Chapters 17 · Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders (Q00-QA1)

Excludes 21

inborn errors of metabolism (E70-E88)

Note1

Codes from this chapter are not for use on maternal records

QA1 · Genetic disorders associated with neoplasms, not elsewhere classified

Excludes 21

multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Code also4
  • , if applicable, any associated conditions, such as:
  • genetic susceptibility to malignant neoplasm by site (Z15.0-)
  • malignant neoplasms (C00.0-C96.9)
  • personal history of malignant neoplasm (Z85.-)
Official index references

Official index references (2)

Susceptibility to disease, genetic (1)
Syndrome (1)

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2026-10-01

Previous assignment: Z15.09

History

Code history

Latest recorded change · FY2027

ChangedUnchanged
FY2027Selected edition

Effective from

  • Added

Lynch syndrome

Billable diagnosis code

CDC/NCHS · FY2027

All editions (1)

All editionsEffective fromCode history
FY20272026-10-01Added

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.